Alliancebernstein L.P. Spero Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $9,571 - $96,228	-12,934 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.09 - $18.77 $13,090 - $18,770	1,000 Added 8.38%	12,934 $207,000
Q3 2021 Nov 10, 2021	SELL	$13.03 - $19.51 $29,969 - $44,873	-2,300 Reduced 16.16%	11,934 $220,000
Q2 2021 Jul 30, 2021	BUY	$12.22 - $15.79 $41,548 - $53,686	3,400 Added 31.38%	14,234 $199,000
Q4 2020 Feb 08, 2021	SELL	$11.65 - $22.07 $22,135 - $41,933	-1,900 Reduced 14.92%	10,834 $210,000
Q2 2020 Aug 13, 2020	BUY	$7.27 - $14.18 $92,576 - $180,568	12,734 New	12,734 $172,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.